60 Degrees Pharmaceuticals (SXTP) EPS (Basic) (QoQ) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) EPS (Basic) (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.13% |
| Dec 31, 2025 | 42.04% |
| Sep 30, 2025 | 46.48% |
| Jun 30, 2025 | 24.58% |
| Mar 31, 2025 | 67.43% |
| Dec 31, 2024 | -3.13% |
| Sep 30, 2024 | 77.99% |
| Jun 30, 2024 | -1,254.73% |
| Mar 31, 2024 | 105.81% |
| Dec 31, 2023 | -168.20% |
| Sep 30, 2023 | 154.81% |
| Jun 30, 2023 | -24.29% |
| Mar 31, 2023 | -61.34% |
| Dec 31, 2022 | -14.88% |
| Sep 30, 2022 | 33.44% |